Expression of ADAM-17, TIMP-3 and fractalkine in the human adult brain endothelial cell line, hCMEC/D3, following pro-inflammatory cytokine treatment

Journal of Neuroimmunology

Volumn 210, Issue 1-2, 2009, Pages 108-112

  Hurst, Louise A ^a   Bunning, Rowena A D ^a   Couraud, Pierre Olivier ^b,c   Romero, Ignacio A ^d   Weksler, Babette B ^e   Sharrack, Basil ^f   Woodroofe, M Nicola ^a  

^a SHEFFIELD HALLAM UNIVERSITY   (United Kingdom)

^b INSTITUT COCHIN   (France)

^c INSERM   (France)

^d OPEN UNIVERSITY   (United Kingdom)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

ADAM 17; Endothelial cells; Fractalkine; Multiple sclerosis

Indexed keywords

CYTOKINE; FRACTALKINE; MESSENGER RNA; PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CELL; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENDOTHELIUM CELL; EXPERIMENTAL MODEL; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WHITE MATTER;

ADAM PROTEINS; CELL LINE; CHEMOKINE CX3CL1; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; ENCEPHALITIS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 67349151265     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.02.008     Document Type: Article

References (33)

1. Amour A., Slocombe P.M., Webster A., Butler M., Knight C.G., Smith B.J., Stephens P.E., Shelley C., Hutton M., Knauper V., Docherty A.J., and Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435 (1998) 39-44
2. Amour A., Knight C.G., Webster A., Slocombe P.M., Stephens P.E., Knäuper V., Docherty A.J.P., and Murphy G. The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473 (2000) 275-279
3. Ancuta P., Rao R., Moses A., Mehle A., Shaw S.K., Luscinskas F.W., and Gabuzda D. Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197 (2003) 1701-1707
4. Bazan J.F., Bacon K.B., Hardiman G., Wang W., Soo K., Rossi D., Greaves D.R., Zlotnik A., and Schall T.J. A new class of membrane-bound chemokine with a CX3C motif. Nature 385 (1997) 640-644
5. Black R.A., Rauch C.T., Kozlosky C.J., Peschon J.J., Slack J.L., Wolfson M.F., Castner B.J., Stocking K.L., Reddy P., Srinivasan S., Nelson N., Boiani N., Schooley K.A., Gerhart M., Davis R., Fitzner J.N., Johnson R.S., Paxton R.J., March C.J., and Cerretti D.P. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385 (1997) 729-733
6. Bzowska M., Jura N., Lassak A., Black R.A., and Bereta J. Tumour necrosis factor-alpha stimulates expression of TNF-alpha converting enzyme in endothelial cells. Eur. J. Biochem. 271 (2004) 2808-2820
7. Clark A.K., Yip K.P., Grist J., Gentry C., Staniland A.A., Marchand F., Dehvari M., Wotherspoon G., Winter J., Ullah J., Bevan S., and Malcangio M. Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain. PNAS 104 25 (2007) 10655-10660
8. Garcia G.E., Xia Y., Chen S., Wang Y., Ye R.D., Harrison J.K., Bacon K.B., Zerwes H.G., and Feng L. NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J. Leukoc. Biol. 67 (2000) 577-584
9. Garton K.J., Gough P.J., Blobel C.P., Murphy G., Greaves D.R., Dempsey P.J., and Raines E.W. Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J. Biol. Chem. 276 (2001) 37993-38001
10. Goddard D.R., Bunning R.A., and Woodroofe M.N. Astrocyte and endothelial cell expression of ADAM 17 (TACE) in adult human CNS. Glia 34 (2001) 267-271
11. Gomis-Ruth F.X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G.P., Bartunik H., and Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389 (1997) 77-81
12. Harkness K.A., Sussman J.D., Davies-Jones G.A.B., Greenwood J., and Woodroofe M.N. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. J. Neuroimmunol. 142 (2003) 1-9
13. Huang D., Shi F.D., Jung S., Pien G.C., Wang J., Salazar-Mather T.P., He T.T., Weaver J.T., Ljunggren H.G., Biron C.A., Littman D.R., and Ransohoff R.M. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J. 20 (2006) 896-905
14. Hulshof S., van Haastert E.S., Kuipers H.F., van den Elsen P.J., De Groot C.J., van der Valk P., Ravid R., and Biber K. CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J. Neuropathol. Exp. Neurol. 62 (2003) 899-907
15. Hundhausen C., Misztela D., Berkhout T.A., Broadway N., Saftig P., Reiss K., Hartmann D., Fahrenholz F., Postina R., Matthews V., Kallen K.J., Rose-John S., and Ludwig A. The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood 102 (2003) 1186-1195
16. Imai T., Hieshima K., Haskell C., Baba M., Nagira M., Nishimura M., Kakizaki M., Takagi S., Nomiyama H., Schall T.J., and Yoshie O. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 91 (1997) 521-530
17. Kastenbauer S., Koedel U., Wick M., Kieseier B.C., Hartung H.P., and Pfister H.W. CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system. J. Neuroimmunol. 137 (2003) 210-217
18. Killar L., White J., Black R., and Peschon J. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE). Ann. N.Y. Acad. Sci. 878 (1999) 442-452
19. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(- Delta Delta C(T)) method. Methods 25 (2001) 402-408
20. Moon S.O., Kim W., Sung M.J., Lee S., Kang K.P., Kim D.H., Lee S.Y., So J.N., and Park S.K. Resveratrol suppresses tumor necrosis factor-alpha-induced fractalkine expression in endothelial cells. Mol. Pharmacol. 70 (2006) 112-119
21. Moss M.L., Jin S.L., Milla M.E., Bickett D.M., Burkhart W., Carter H.L., Chen W.J., Clay W.C., Didsbury J.R., Hassler D., Hoffman C.R., Kost T.A., Lambert M.H., Leesnitzer M.A., McCauley P., McGeehan G., Mitchell J., Moyer M., Pahel G., Rocque W., Overton L.K., Schoenen F., Seaton T., Su J.L., and Becherer J.D. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385 (1997) 733-736
22. Pan Y., Lloyd C., Zhou H., Dolich S., Deeds J., Gonzalo J.A., Vath J., Gosselin M., Ma J., Dussault B., Woolf E., Alperin G., Culpepper J., Gutierrez-Ramos J.C., and Gearing D. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387 (1997) 611-617
23. Plumb J., Cross A.K., Surr J., Haddock G., Smith T., Bunning R.A., and Woodroofe M.N. ADAM-17 and TIMP3 protein and mRNA expression in spinal cord white matter of rats with acute experimental autoimmune encephalomyelitis. J. Neuroimmunol. 164 (2005) 1-9
24. Plumb J., McQuaid S., Cross A.K., Surr J., Haddock G., Bunning R.A., and Woodroofe M.N. Upregulation of ADAM-17 expression in active lesions in multiple sclerosis. Mult. Scler. 12 (2006) 375-385
25. Rieckmann P., Michel U., Albrecht M., Bruck W., Wockel L., and Felgenhauer K. Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J. Neuroimmunol. 60 (1995) 9-15
26. Schafer A., Schulz C., Eigenthaler M., Fraccarollo D., Kobsar A., Gawaz M., Ertl G., Walter U., and Bauersachs J. Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood 103 (2004) 407-412
27. Schulz C., Schafer A., Stolla M., Kerstan S., Lorenz M., von Bruhl M.L., Schiemann M., Bauersachs J., Gloe T., Busch D.H., Gawaz M., and Massberg S. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation 116 (2007) 764-773
28. Soriano S.G., Amaravadi L.S., Wang Y.F., Zhou H., Yu G.X., Tonra J.R., Fairchild-Huntress V., Fang Q., Dunmore J.H., Huszar D., and Pan Y. Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury. J. Neuroimmunol. 125 (2002) 59-65
29. Sunnemark D., Eltayeb S., Nilsson M., Wallstrom E., Lassmann H., Olsson T., Berg A.L., and Ericsson-Dahlstrand A. CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflammation 2 (2005) 17
30. Suzuki F., Nanki T., Imai T., Kikuchi H., Hirohata S., Kohsaka H., and Miyasaka N. Inhibition of CX3CL1 (fractalkine) improves experimental autoimmune myositis in SJL/J mice. J. Immunol. 175 (2005) 6987-6996
31. Tsou C.L., Haskell C.A., and Charo I.F. Tumor necrosis factor-alpha-converting enzyme mediates the inducible cleavage of fractalkine. J. Biol. Chem. 276 (2001) 44622-44626
32. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., and Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
33. Yang X.P., Mattagajasingh S., Su S., Chen G., Cai Z., Fox-Talbot K., Irani K., and Becker L.C. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ. Res. 101 (2007) 1001-1008